within Pharmacolibrary.Drugs.ATC.B;

model B05BC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.83 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.00020999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mannitol is an osmotic diuretic used to reduce intracranial pressure, manage cerebral edema, and promote diuresis in acute renal failure or to excrete toxic substances. It is approved for intravenous use in various acute medical settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult healthy volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Cloyd, JC, et al., &amp; Lakatua, DJ (1986). Mannitol pharmacokinetics and serum osmolality in dogs and humans. <i>The Journal of pharmacology and experimental therapeutics</i> 236(2) 301–306. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3080582/&quot;>https://pubmed.ncbi.nlm.nih.gov/3080582</a></p></li><li><p>Burness, CB, &amp; Keating, GM (2012). Mannitol dry powder for inhalation: in patients with cystic fibrosis. <i>Drugs</i> 72(10) 1411–1421. DOI:<a href=&quot;https://doi.org/10.2165/11208950-000000000-00000&quot;>10.2165/11208950-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22755516/&quot;>https://pubmed.ncbi.nlm.nih.gov/22755516</a></p></li><li><p>Chiam, E, et al., &amp; Bellomo, R (2015). Paracetamol: a review with specific focus on the haemodynamic effects of intravenous administration. <i>Heart, lung and vessels</i> 7(2) 121–132. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26157738/&quot;>https://pubmed.ncbi.nlm.nih.gov/26157738</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05BC01;
